BenignSyndrome
McCune-Albright Syndrome
Synonyms: MAS, polyostotic Fibrous dysplasia with precocious puberty
SYSTEMIC GENETIC Syndrome
Quick Facts
Behaviour
Benign
Category
Syndrome
Grade
Not set
Synonyms
- MAS
- polyostotic Fibrous dysplasia with precocious puberty
Category
Syndrome
Behaviour
Benign
Gender
Female
Tissue of Origin
Bone
Epidemiology
- Somatic GNAS mutations (post-zygotic)
- Sporadic presentation (not inherited)
- Affects 1 in 25,000 live births
- Female predominance in presentation
- Highly Variable phenotype
Clinical Features
- Cafe-au-lait spots (characteristic coast of Maine pattern)
- Precocious puberty (especially girls)
- Polyostotic Fibrous dysplasia
- Endocrinopathies: hyperthyroidism, hyperparathyroidism
- Growth hormone excess
- Cardiac arrhythmias possible
Location
- Femur and pelvis most common
- Polyostotic: multiple Bones affected
- Often asymmetric distribution
Imaging
- Skeletal survey: Fibrous dysplasia distribution
- Hormonal imaging: pituitary MRI, thyroid ultrasound
- Cardiac evaluation if indicated
Pathology
- Fibrous dysplasia on biopsy
- Benign fibroblastic tissue with immature woven Bone
Genetics
- GNAS somatic mutations (post-zygotic)
- Different from germline GNAS (pseudohypoparathyroidism)
- Variable tissue involvement by mutation timing
Treatment
- Observation of stable Fibrous dysplasia
- Bisphosphonates for symptomatic Bone disease
- Endocrinology management: GnRH agonists for precocious puberty
- Surgical correction if severe deformity
Prognosis
- Benign Fibrous dysplasia
- Malignant transformation rare (0.5%)
- Prognosis depends on endocrine complications
Key Points
- SYSTEMIC GENETIC Syndrome
- GNAS somatic mutations
- Cafe-au-lait spots + precocious puberty classic
- Polyostotic Fibrous dysplasia characteristic
- Malignancy risk Low but present
Workup - Blood Tests
- Hormone screening: LH, FSH, testosterone/estradiol (precocious puberty)
- TSH, free T4 (hyperthyroidism)
- Calcium, phosphate, PTH (hyperparathyroidism)
- Growth hormone (gigantism)
Workup - Local Imaging
- Skeletal survey: assess FD extent
- Pelvic imaging: screen for ovarian cysts (source of precocity)
- MRI brain: pituitary assessment if GH excess
- Thyroid ultrasound
Workup - Biopsy
- Not required for diagnosis
- If Fibrous dysplasia uncertain on imaging
Workup - Staging
- Baseline imaging: whole skeleton
- Hormonal assessment: comprehensive screen
Workup - Other
- Endocrinology consultation
- Genetics counselling
- Ophthalmology: screen for vision problems
- Cardiac evaluation if arrhythmias
Follow-up Summary
- Regular endocrinology Follow-up: hormone monitoring
- Annual skeletal imaging if progressive symptoms
- Monitor for Malignant transformation
- Screen for additional endocrine complications